SCHEMBL7335437

SCHEMBL7335437

CCOC(=O)c1ccc(N)cc1N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.43
▸ MAOA P21397 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ GAA P10253 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SYK P43405 1/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ CHRM3 P20309 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ HTR3A P46098 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7333000 0.92 RAB9A (0.39) LMNAMAOACYP1A2CYP3A4ALDH1A1
SCHEMBL8896516 0.84 RAB9A (0.44) LMNAALDH1A1HSD17B10MAPTRAB9A
SCHEMBL7340687 0.83 ALDH1A1 (0.41) LMNAALDH1A1HSD17B10GAAMAPT
SCHEMBL7329464 0.81 SMN1; SMN2 (0.53) LMNAALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL7328886 0.80 SMN1; SMN2 (0.47) CYP3A4ALDH1A1HSD17B10MAPTALOX15
SCHEMBL3418853 0.78 MAOA (0.50) LMNAMAOACYP1A2CYP3A4ALDH1A1
SCHEMBL20251278 0.78 NR1H2 (0.39) CYP3A4ALDH1A1HSD17B10GAAMAPT
SCHEMBL15357999 0.77 KDM4E (0.38) LMNACYP1A2CYP3A4ALDH1A1MAPT
SCHEMBL16529730 0.77 SYK (0.41) LMNAALDH1A1MAPTSYKCA12
Hydrochloric Acid SCHEMBL2876219 0.77 MAOA (0.49) LMNAMAOACYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 — — US disclosed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 — — WO disclosed
Send feedback